Skip to main content
. 2017 Feb 5;130(3):347–356. doi: 10.4103/0366-6999.198924

Table 3.

Relative mRNA expression of PDGF-B and BMP-6 in the cortical defect area analyzed by qRT-PCR

Groups (n = 3) BMP-6 PDGF-B


Day 1 Day 3 Day 7 Day 14 Day 1 Day 3 Day 7 Day 14
S 1.20 ± 0.12 1.00 ± 0.13 1.01 ± 0.21 1.01 ± 0.11 1.07 ± 0.49 1.01 ± 0.19 1.01 ± 0.13 1.01 ± 0.14
K 1.36 ± 0.32 1.46 ± 0.53 1.46 ± 0.30 1.76 ± 0.13 0.74 ± 0.25 0.72 ± 0.36 0.92 ± 0.08 1.94 ± 0.51
F 2.05 ± 0.27 4.36 ± 0.14*,† 2.34 ± 0.59* 3.50 ± 0.17*,† 1.08 ± 0.25 1.13 ± 0.20 1.03 ± 0.06 2.39 ± 0.56*
N 5.18 ± 0.68*,†,‡ 2.86 ± 0.28*,† 4.82 ± 0.76*,†,‡ 5.37 ± 0.84*,†,‡ 4.68 ± 0.20*,†,‡ 2.94 ± 0.33*,†,‡ 2.31 ± 0.31*,†,‡ 4.04 ± 0.80*,†

Values represent the mean ± SD of three animals for each group. *P<0.05 versus groups S; P<0.05 versus groups K; P<0.05 versus groups F. BMP-6: Bone morphogenetic protein-6; PDGF-B: Platelet-derived growth factor-B; qRT-PCR: Quantitative real-time polymerase chain reaction; S: Saline; K: Empty nanocapsules; F: Free 15-Deoxy-△12,14-prostaglandin J2; N: 15-Deoxy-△12,14-prostaglandin J2 nanocapsules; SD: Standard deviation; mRNA: Messenger RNA.